Claims for Patent: 12,171,739

Summary for Patent: 12,171,739

Title:	N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
Abstract:	This invention provides compounds of Formula I wherein B, G, A, E, R1, R2, R3, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
Inventor(s):	Joseph P. Lyssikatos, Julie Marie Hicks, Fredrik P. Marmsater, Qian Zhao
Assignee:	Array Biopharma Inc
Application Number:	US17/940,902
Patent Claims:	1. A compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein: A is O, C(═O), S, SO or SO2; G is N; B represents a fused 6-membered heteroaryl ring; E is X is N or CH; D1, D2 and D3 are independently N or CR19; D4 and D5 are independently N or CR19 and D6 is O, S, or NR20, wherein at least one of D4 and D5 is not CR19; D7, D8, D9 and D10 are independently N or CR19, wherein at least one of D7, D8, D9 and D10 is N; R1 is H or alkyl; each R2 is independently halogen, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, —SR18, —OR15, —C(O)R15, —C(O)OR15, —NR14C(O)OR18, —OC(O)R15, —NR14SO2R18, —SO2NR15R14, —NR14C(O)R15, —C(O)NR15R14, —NR15C(O)NR15R14, —NR13C(NCN)NR15R14, —NR15R14, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, cycloalkylalkyl, —S(O)p(alkyl), —S(O)p(CR13R14)q-aryl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, saturated or partially unsaturated heterocyclyl, heterocyclylalkyl, —O(CR13R14)q-aryl, —NR15(CR13R14)q-aryl, —O(CR13R14)q-heteroaryl, —NR13(CR13R14)q-heteroaryl, —O(CR13R14)q-heterocyclyl or —NR15(CR13R14)q-heterocyclyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from oxo, halogen, cyano, nitro, trifluoromethyl, difluoromethoxy, trifluoromethoxy, azido, —NR13SO2R18, —SO2NR15R13, —C(O)R15, —C(O)OR15, —OC(O)R15, —NR13C(O)OR18, —NR13C(O)R15, —C(O)NR15R13, —NR15R13, —NR14C(O)NR15R13, —NR14C(NCN)NR15R13, —OR15, aryl, heteroaryl, arylalkyl, heteroarylalkyl, saturated and partially unsaturated heterocyclyl, and heterocyclylalkyl, and wherein said aryl, heteroaryl, arylalkyl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl rings may be further substituted with one or more groups selected from halogen, hydroxyl, cyano, nitro, azido, fluoromethyl, difluoromethyl, trifluoromethyl, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, NR15R13 and OR15; each R3 is independently Q, Z, halogen, cyano, nitro, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, trifluoromethoxy, difluoromethoxy, fluoromethoxy, trifluoromethyl, difluoromethyl, fluoromethyl, OR15, NR15R16, NR15OR16, NR15C(═O)OR18, NR15C(═O)R16, SO2NR15R16, SR15, SOR15, SO2R15, C(═O)R15, C(═O)OR15, OC(═O)R15, C(═O)NR15R16, NR15C(═O)NR16R17, NR15C(═NCN)NR16R17, or NR15C(═NCN)R16, wherein said alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyclyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl are optionally substituted with one or more groups independently selected from halogen, oxo, cyano, nitro, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, trifluoromethoxy, difluoromethoxy, fluoromethoxy, trifluoromethyl, difluoromethyl, fluoromethyl, OR15, NR15R16, NR15OR16, NR15C(═O)OR18, NR15C(═O)R16, SO2NR15R16, SR15, SOR15, SO2R15, C(═O)R15, C(═O)OR15, OC(═O)R15, C(═O)NR15R16, NR15C(═O)NR16R17, NR15C(═NCN)NR16R17, NR15C(═NCN)R16, (C1-C4 alkyl)NRaRb and NR15C(O)CH2ORa; or R3 is a 5-6 membered heterocyclic ring containing from 1 to 4 heteroatoms selected from N, O, S, SO and SO2 and substituted with -M1-M2-M3-M4 or -M1-M5, wherein M1 is C1-C4 alkyl, wherein optionally a CH2 is replaced by a C(═O) group; M2 is NRe or CReRf, M3 is C1-C4 alkyl; M4 is CN, NRe(O)0-2Rf, S(O)0-2NRgRh, CORgRh, S(O)0-2Rf, or CO2Rf, and M5 is NRgRh, wherein Re, Rf, Rg and Rh are independently H or C1-C4 alkyl, or Rg and Rh together with the nitrogen atom to which they are attached form a 5- or 6-membered ring optionally containing 1 or 2 additional heteroatoms selected from N, O, S, SO and SO2 in which any ring nitrogen atom present is optionally substituted with a C1-C4 alkyl group and which ring may optionally have one or two oxo or thiooxo substituents; Q is Z is selected from and tautomers thereof; W and V are independently O, NR6, S, SO, SO2, CR7R8, CR8R9 or C═O; W2 is O or S; Y is S, SO, SO2, CR7CR8, or CR8R9, provided that when W is O, NR6, S, SO, or SO2, then V is CR8R9, and when V is O, NR6, S, SO, or SO2, then W and Y are each CR8R9; R8b is H or C1-C6 alkyl; each R6, R8, R8a and R9 are independently hydrogen, trifluoromethyl, alkyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, or heterocyclylalkyl, wherein said alkyl, cycloalkyl, heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, OR15, NR15R16, SR15, S(═O)R15, SO2R15, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl, or R8 and R8a together with the atom to which they are attached form a 3 to 6 membered carbocyclic ring; R7 is hydrogen, halogen, cyano, nitro, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclylalkyl, —NR15SO2R16 —SO2NR15R16, —C(O)R15, —C(O)OR15, —OC(O)R15, —NR15C(O)OR18, —NR15C(O)R16, —C(O)NR15R16, —NR15R16, —NR15C(O)NR16R17, —OR15, —S(O)R15, —SO2R15, or SR15, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl, are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, —NR15SO2R16—SO2NR15R16, —C(O)R15, —C(O)OR15, —OC(O)R15, —NR15C(O)OR18, —NR15C(O)R16, —C(O)NR15R16, —NR15R16, —NR15C(O)NR16R17, —OR15, —S(O)R15, —SO2R15, SR15, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl; R10 is hydrogen, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclylalkyl, —NR15C(O)OR18, —NR15C(O)R16, —NR15R16, or —OR15, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclylalkyl, are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, —NR15SO2R16—SO2NR15R16, —C(O)R15, —C(O)OR15, —OC(O)R15, —NR15C(O)OR18, —NR15C(O)R16, —C(O)NR15R16, —NR15R16, —NR15C(O)NR16R17, —OR15, —S(O)R15, —SO2R15, SR15, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl; or R6 and R8 together with the atoms to which they are attached form a 3 to 10 membered saturated or partially unsaturated heterocyclyl ring optionally containing one or more additional heteroatoms selected from N, O, S, SO, SO2 and NR6, wherein said carbocyclic and heterocyclic rings are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, OR15, NR15R16, SR15, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl; or R7 and R8 together with the atoms to which they are attached form a 3 to 10 membered saturated or partially unsaturated cycloalkyl or heterocyclyl ring optionally containing one or more additional heteroatoms selected from N, O, S, SO, SO2 and NR6, wherein said carbocyclic and heterocyclic rings are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, OR15, NR15R16, SR15, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl; or R8 and R9 together with the atoms to which they are attached form a 3 to 10 membered saturated or partially unsaturated cycloalkyl or heterocyclyl ring optionally containing one or more additional heteroatoms selected from N, O, S, SO, SO2 and NR6, wherein said carbocyclic and heterocyclic rings are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, OR15, NR15R16, SR15, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl; or R6 and R10 together with the atoms to which they are attached form a 3 to 10 membered saturated or partially unsaturated heterocyclyl ring optionally containing one or more additional heteroatoms selected from N, O, S, SO, SO2 and NR6, wherein said heterocyclic ring is optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, OR15, NR15R16, SR15, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl; or R8 and R10 together with the atoms to which they are attached form a 3 to 10 membered saturated or partially unsaturated heterocyclyl ring optionally containing one or more additional heteroatoms selected from N, O, S, SO, SO2 and NR6, wherein said heterocyclic ring is optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, OR15, NR15R16, SR15, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl; each R12 is independently halogen, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, —SR18, —OR15, —C(O)R15, —C(O)OR15, —NR14C(O)OR18, —OC(O)R15—NR14SO2R18, —SO2NR15R14, —NR14C(O)R15, —C(O)NR15R14, —NR13C(O)NR15R14, —NR13C(NCN)NR15R14, —NR15R14, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, cycloalkylalkyl, —S(O)p(alkyl), —S(O)p(CR13R14)q-aryl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, saturated or partially unsaturated heterocyclyl, heterocyclylalkyl, —O(CR13R14)q-aryl, —NR15(CR13R14)q-aryl, —O(CR13R14)q-heteroaryl, —NR13(CR13R14)q-heteroaryl, —O(CR13R14)q-heterocyclyl or —NR15(CR13R14)q-heterocyclyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from oxo, halogen, cyano, nitro, trifluoromethyl, difluoromethoxy, trifluoromethoxy, azido, —NR13SO2R18, —SO2NR15R13, —C(O)R15, —C(O)OR15, —OC(O)R15, —NR13C(O)OR18, —NR13C(O)R15, —C(O)NR15R13, —NR15R13, —NR14C(O)NR15R13, —NR14C(NCN)NR15R13, —OR15, aryl, heteroaryl, arylalkyl, heteroarylalkyl, saturated and partially unsaturated heterocyclyl, and heterocyclylalkyl, and wherein said aryl, heteroaryl, arylalkyl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl rings may be further substituted with one or more groups selected from halogen, hydroxyl, cyano, nitro, azido, fluoromethyl, difluoromethyl, trifluoromethyl, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, NR15R13 and OR15; R13 and R14 are independently hydrogen or alkyl, or R13 and R14 together with the atoms to which they are attached form a saturated or partially unsaturated cycloalkyl, or saturated or partially unsaturated heterocyclyl ring, wherein said alkyl, cycloalkyl and heterocyclyl portions are optionally substituted with one or more groups independently selected from halogen, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O)ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, and NRaC(═O)NRbRc; R15, R16 and R17 are independently H, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, or heterocyclylalkyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl are optionally substituted with one or more groups independently selected from alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, aryl, heteroaryl, halogen, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O)ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, NRaC(═O)NRbRc, OC(═O)NRaRb, and C(═O)CH2ORa; or any two of R15, R16 and R17 together with the atom to which they are attached form a heterocyclic ring optionally containing one or more additional heteroatoms selected from N, O, S, SO, SO2 and NR6, wherein said heterocyclic ring is optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, ORa, NRaRb, SRa, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl, or R13 and R15 together with the atom to which they are attached form a saturated or partially unsaturated cycloalkyl or saturated or partially unsaturated heterocyclyl ring, wherein said cycloalkyl and heterocyclyl are optionally substituted with one or more groups independently selected from halogen, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O) ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, and NRaC(═O)NRbRc; R18 is CF3, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, or heterocyclylalkyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl and heterocyclylalkyl are optionally substituted with one or more groups independently selected from alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, aryl, heteroaryl, halogen, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O)ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, NRaC(═O)NRbRc, or R15 and R18 together with the atoms to which they are attached form a saturated or partially unsaturated cycloalkyl or saturated or partially unsaturated heterocyclyl ring, wherein said cycloalkyl and heterocyclyl are optionally substituted with one or more groups independently selected from halogen, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O)ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, and NRaC(═O)NRbRc; each R19 is independently H, halogen, cyano, nitro, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, —SR18, —OR15, —C(O)R15, —C(O)OR15, —NR14C(O)OR18, —OC(O)R15—NR14SO2R18, —SO2NR15R14, —NR14C(O)R15, —C(O)NR15R14, —NR13C(O)NR15R14, —NR13C(NCN)NR15R14, —NR15R14, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, cycloalkylalkyl, —S(O)p(alkyl), —S(O)p(CR13R14)q-aryl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, saturated or partially unsaturated heterocyclyl, heterocyclylalkyl, —O(CR13R14)q-aryl, —NR15(CR13R14)q-aryl, —O(CR13R14)q-heteroaryl, —NR13(CR13R14)q-heteroaryl, —O(CR13R14)q-heterocyclyl or —NR15(CR13R14)q-heterocyclyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl and heterocyclylalkyl portions are optionally substituted with one or more groups independently selected from oxo, halogen, cyano, nitro, trifluoromethyl, difluoromethoxy, trifluoromethoxy, azido, —NR13SO2R18, —SO2NR15R13, —C(O)R15, —C(O)OR15, —OC(O)R15, —NR13C(O)OR18, —NR13C(O)R15, —C(O)NR15R13, —NR15R13, —NR14C(O)NR15R13, —NR14C(NCN)NR15R13, —OR15, aryl, heteroaryl, arylalkyl, heteroarylalkyl, saturated or partially unsaturated heterocyclyl, and heterocyclylalkyl, and wherein said aryl, heteroaryl, arylalkyl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl rings may be further substituted with one or more groups selected from halogen, hydroxyl, cyano, nitro, azido, fluoromethyl, difluoromethyl, trifluoromethyl, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, NR15R13 and OR15, each R20 is independently C1-C4 alkyl, saturated or partially unsaturated cycloalkyl, trifluoromethyl, difluoromethyl, or fluoromethyl; Ra, Rb and Rc are independently H, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, aryl, or heteroaryl, or NRaRb forms a 5-6 membered heterocyclic ring having 1-2 ring nitrogen atoms and optionally substituted with (C1-C3 alkyl), or NRbRc forms a 5-6 membered heterocyclic ring having 1-2 ring nitrogen atoms; j is 0, 1, 2 or 3; m is 1, 2, 3, or 4; n is 0, 1, 2, 3, or 4; q is 0, 1, 2, 3, 4, or 5; and p is 0, 1 or 2. 2. The compound of claim 1, wherein: each R3 is independently Q, Z, halogen, cyano, nitro, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, trifluoromethoxy, difluoromethoxy, fluoromethoxy, trifluoromethyl, difluoromethyl, fluoromethyl, OR15, NR15R16, NR15OR16, NR15C(═O)OR18, NR15C(═O)R16, SO2NR15R16, SR15, SOR15, SO2R15, C(═O)R15, C(═O)OR15, OC(═O)R15, C(═O)NR15R16, NR15C(═O)NR16R17, NR15C(═NCN)NR16R17, or NR15C(═NCN)R16, wherein said alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, cycloalkyl, heterocyclyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl are optionally substituted with one or more groups independently selected from halogen, oxo, cyano, nitro, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, trifluoromethoxy, difluoromethoxy, fluoromethoxy, trifluoromethyl, difluoromethyl, fluoromethyl, OR15, NR15R16, NR15OR16, NR15C(═O)OR18, NR15C(═O)R16, SO2NR15R16, SR15, SOR15, SO2R15, C(═O)R15, C(═O)OR15, OC(═O)R15, C(═O)NR15R16, NR15C(═O)NR16R17, NR15C(═NCN)NR16R17, and NR15C(═NCN)R16; Z is selected from each R6, R8, R8a and R9 are independently hydrogen, trifluoromethyl, alkyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, or heterocyclylalkyl, wherein said alkyl, cycloalkyl, heterocyclyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl are optionally substituted with one or more groups independently selected from oxo, halogen, alkyl, alkenyl, alkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, cycloalkylalkyl, cyano, nitro, OR15, NR15R16, SR15, S(═O)R15, SO2R15, trifluoromethyl, difluoromethyl, fluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, azido, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and heterocyclylalkyl; R15, R16 and R17 are independently H, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, or heterocyclylalkyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl are optionally substituted with one or more groups independently selected from alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, aryl, heteroaryl, halogen, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O)ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, and NRaC(═O)NRbRc, and Ra, Rb and Rc are independently H, alkyl, alkenyl, alkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, aryl, or heteroaryl. 3. The compound of claim 1, wherein G is N and A is O or S. 4. The compound according to claim 1, wherein E is selected from 5. The compound of claim 4, wherein E is selected from the structures: wherein k is 0, 1, 2, or 3. 6. The compound of claim 5, wherein E is selected from the structures: 7. The compound according to claim 1, wherein E is selected from 8. The compound of claim 7, wherein E is selected from the structures: wherein each R12 group and each R19 group is independent of the other. 9. The compound of claim 8, wherein E is selected from: 10. The compound according to claim 1, wherein m is 1 and R3 is Z. 11. The compound of claim 10, wherein Z is selected from in which W is O or S; W2 is O or S; and V is CR8R9. 12. The compound of claim 11, wherein: Z is selected from the structures: R6 is H or C1-C6 alkyl; and R8 and R8a are independently H or C1-C6 alkyl optionally substituted with ORa in which Ra is H or C1-C6 alkyl, or R8 and R8a together with the atom to which they are attached form a C3-C6 cycloalkyl ring. 13. The compound of claim 12, wherein m is 1 and R3 is selected from the structures: 14. The compound according to claim 1, wherein m is 1 and R3 is OR15. 15. The compound of claim 14, wherein R15 is (i) H; (ii) C3-C6 cycloalkyl optionally substituted with ORa; (iii) cycloalkylalkyl; (iv) C1-C6 alkyl optionally substituted with one or two groups independently selected from —ORa, —OC(O)Ra, —CO2Ra, —SO2Ra, —SRa, —C(O)NRaRb, —NRaRb, —NRaC(O)Rb, —OC(O)NRaRb, and NRaC(O)NRbRc; (v) a 5-6 membered heterocyclic ring having a ring heteroatom selected from N and O and optionally substituted with —C(O)Ra, C1-C6 alkyl, —C(O)NRaRb, —SO2Ra, or C(O)CH2ORa; (vi) heterocyclylalkyl, wherein said heterocyclic portion is a 5-6 membered ring having 1 or 2 ring heteroatoms independently selected from N and O and is optionally substituted with C1-C6 alkyl, halogen, ORa or oxo; (vii) a 5-6 membered heteroaryl ring having from 1 to three ring nitrogen atoms and optionally substituted with C1-C6 alkyl or halogen; or (viii) heteroarylalkyl, wherein said heteroaryl portion is a 5-6 membered ring having 1-2 ring nitrogen atoms and is optionally substituted with C1-C6 alkyl. 16. The compound of claim 15, wherein R3 is: (i) OH; (ii) cyclopentanoxy, 2-hydroxycyclopentoxy, or cyclohexanoxy; (iii) 1-cyclopropylmethoxy; (iv) CH3O—, CH3CH2O—, CH3O(CH2)2O—, CH3CH2O(CH2)2O—, HO(CH2)2O—, HOCH2CH(OH)CH2O—, CH3CH(OH)CH2O—, HOC(CH3)2CH2O—, (PhCH2O)CH2CH2O—, (PhCH2)OCH2CH(OH)CH2O—, —O—(CH2)2O C(O)CH3, —O—(CH2) CO2CH3, —O(CH2)3SO2CH3, —O(CH2)3SCH3, —OCH2C(O)N(CH3)2, —OCH2C(O)NH(CH3), —OCH2C(O)NH2, —O(CH2)3N(CH3)2, —O(CH2)2N(CH3)2, —O(CH2)2NHC(O)CH3, —O(CH2)2NHC(O)CH2CH3, —O(CH2)2OC(O)N(CH3)2, (v) (vi), (vii) 2-methylpyridin-4-yloxy, 2-chloropyridin-4-yloxy, or 2-methylpyridin-4-yloxy; or (viii) 17. The compound according to claim 16, wherein m is 1 and R3 is: (i) a 5 membered heterocyclic ring having a ring nitrogen atom and optionally having a second ring heteroatom selected from N and O, wherein said heterocyclic ring is optionally substituted with one or two groups independently selected from C1-C6 alkyl, oxo and (CH2)1-2NRaRb; (ii) a 5-6 membered heteroaryl ring having 1-3 nitrogen atoms, wherein said heteroaryl is linked to the B ring by a ring nitrogen atom; (iii) —NR15C(O)R16 wherein R15 is H or methyl and R16 is selected from: (a) C2-C6 alkenyl optionally substituted with NRaRb, (b) a 5-6 membered heterocyclic ring optionally substituted with C1-C6 alkyl; and (c) C1-C6 alkyl optionally substituted with one or more groups independently selected from C1-C6 alkyl or ORa; (iv) —C(═O)NR15R16 wherein R15 and R16 independently are H or C1-C6 alkyl, or R15 and R16 together with the atom to which they are attached form a 6 membered heterocyclic ring optionally having a second heteroatom selected from N and O and optionally substituted with C1-C6 alkyl; (v) SO2R15 wherein R15 is C1-C6 alkyl or a phenyl group optionally substituted with C1-C6 alkyl; (vi) SOR15 wherein R15 is C1-C6 alkyl; (vii) SR15 wherein R15 is C1-C6 alkyl; (viii) halogen; (ix) R3 is —CO2R15, wherein R15 is a 6 membered heterocyclic ring having one or two ring nitrogen atoms and optionally substituted with C1-C6 alkyl; (x) C1-C6 alkyl optionally substituted with OR15 wherein R15 is H or C1-C6 alkyl; (xi) C3-C6 alkynyl optionally substituted with OR15, NR15C(O)CH2ORa or a 6 membered heterocyclic ring having one or two ring heteroatoms independently selected from N, O, and SO2, wherein R15 and R16 are independently H or C1-C6 alkyl, and Ra is C1-C6 alkyl; (xii) —NR15C(O)NR16R17, wherein R15, R16 and R17 are independently H or C1-C6 alkyl, or R16 and R17 together with the nitrogen atom to which they are attached form a 5-6 membered heterocyclic ring optionally having a second heteroatom selected from N and O and which is optionally substituted with C1-C6 alkyl; or (xiii) heterocyclylalkyl wherein said heterocyclyl portion is a 6 membered ring having a ring nitrogen atom and optionally having a second ring heteroatom selected from N and SO2. 18. The compound of claim 17, wherein R3 is: (i) (ii) 1H-pyrazol-1-yl; (iii) (CH2═CH)—C(O)NH—, (CH3)2NCH2(CH═CH)C(O)NH—, CH3C(O)NH—, (CH3)2C(O)NH—, CH3CH2C(O)N(CH3)—, CH3OCH2C(O)NH—, CH3OCH2C(O)N(CH3)—, CH3CH(OCH3)C(O)NH—, CH3OCH2CH2C(O)NH—, CH3OCH(CH3)C(O)NH—, CH3OCH2CH(CH3)C(O)NH—; (iv) (CH3)2NC(O)—, (4-morpholinyl)C(O)—, or (1-methylpiperazin-4-yl)C(O)—; (v) 4-methylbenzenesulfonate, ethanesulfonate; (vi) ethysulfinyl; (vii) EtS—; (viii) Br; (ix) (1-methylpiperazin-4-yl)CO2—; (x) HO(CH2)3— or CH3O(CH2)3—; (xi) (xii) or (xiii) 19. The compound according to claim 1, wherein: E is selected from R12 is halogen; j is 0 or 1; R19 is H, C1-C6 alkyl, or halogen; and R20 is H; provided that R3 of Formula I is not NR15C(═O)(CH═CH)R16a wherein R16a is H, alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated or partially unsaturated cycloalkyl, saturated or partially unsaturated heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, or heterocyclylalkyl, wherein said alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, and heterocyclylalkyl are optionally substituted with one or more groups independently selected from alkyl, alkenyl, alkynyl, heteroalkyl, heteroalkenyl, heteroalkynyl, saturated and partially unsaturated cycloalkyl, saturated and partially unsaturated heterocyclyl, aryl, heteroaryl, halogen, oxo, ORa, NRaRb, NRaORb, NRaCO2Rb, NRaCORb, SO2NRaRb, SRa, SORa, SO2Ra, S—S—Ra, C(═O)Ra, C(═O)ORa, OC(═O)Ra, C(═O)NRaRb, NRaC(═O)Rb, NRaC(═O)NRbRc, OC(═O)NRaRb, and C(═O)CH2ORa. 20. A composition comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 21. A composition comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable diluent or carrier. 22. A method of preparing a compound of Formula I according to claim 1, comprising: (a) reacting a compound of formula (F1) with a compound of formula (F2) in which Z represents a leaving atom or group.